Global and United States Estrogen and Progesterone In-Depth Research Report 2017-2022

Published: Aug, 2017 | Pages: 112 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Estrogen and Progesterone industry.

Major Companies
    Gedeon Richter Plc.
    Bayer Oy
    N.V.Organon
    Pfizer Healthcare Ireland
    Jenapharm GmbH & Co. KG
    Besins Healthcare Benelux
    MERCK SERONO LIMITED
    Abbott Healthcare Products B.V.
    Teva Pharma - Produtos Farmaceuticos,Lda.
    Aspen Pharmacare Australia Pty Ltd.
    Dr.Kade Pharmazeutische Fabrik GmbH
    F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
    Eli Lilly Nederland B.V
    Orion Corporation
    AstraZeneca UK Limited
    Novartis Pharma Schweiz AG

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main Product Type
Estrogen and Progesterone Market, by Progesterone stimulant
    Norethisterone Acetate
    Ethynodiol diacetate
    Levonorgestrel
    Methylnorethindrone
    Norelgestromin
    Desogestrel
    Etonogestrel
    Gestodene
    Norgestimate
    Drospirenone
    Nomegestrol
    Promegestone
    Trimegestone
    Dienogest
    chlormadinone
    cyproterine
    Medroxyprogesterone acetate
    megestrol
    Gestonorone
    anhydrohydroxy progesterone
    Medrogestone
    Norgestrienone
    Lynestrenol
    Norethynodrel
    Tibolone
    Dydrogesterone
    Quingestanol
Estrogen and Progesterone Market, by Antiprogestogen
    Aglepristone
    Mifepristone
    Asoprisnil
    Telapristone
    Ulipristal acetate
Estrogen and Progesterone Market, by Estrogenic stimulant
    Megestrol
    Estradiol
    Estradiol Acetate
    Estradiol Benzoate
    estradiol cypionate
    Estradiol Dipropionate
    Estradiol enanthate
    Estradiol Undecylate
    Estradiol valerate
    Polyestradiol phosphate 
    Estriol Triacetate
    Piperazine Estrone
    Ethinyl estradiol
    Mestranol
    Promestriene
    Equilenin
    Equilin
    Chlorotrianisene
    Dienoestrol
    Fosfestrol
    Diethylstilbestrol
    Zeranol
Estrogen and Progesterone Market, by Antiestrogen agent
    Afimoxifene
    Arzoxifene
    Bazedoxifene
    Clomifene
    Cyclofenil
    Epimestrol
    Lasofoxifene
    Mepitiostane
    Nafoxidine
    Ormeloxifene
    Raloxifene
    Tamoxifen
    Toremifene
    Fulvestrant
Estrogen and Progesterone Market, by Aromatase Inhibitor
    Aminoglutethimide
    Testolactone
    Anastrozole
    Atamestane
    Exemestane
    Fadrozole
    Formestane
    Letrozole
    Minamestane
    Plomestane
    Vorozole

Main Applications
    Pharmacy
    Hospital
    Department of endocrinology

 Table of Contents

Global and United States Estrogen and Progesterone In-Depth Research Report 2017-2022
Chapter One Global Estrogen and Progesterone Market Overview
    1.1 Global Estrogen and Progesterone Market Sales Volume Revenue and Price 2012-2017
    1.2 Estrogen and Progesterone, by Progesterone stimulant 2012-2017
        1.2.1 Global Estrogen and Progesterone Sales Market Share by Progesterone stimulant 2012-2017
        1.2.2 Global Estrogen and Progesterone Revenue Market Share by Progesterone stimulant 2012-2017
        1.2.3 Global Estrogen and Progesterone Price by Progesterone stimulant 2012-2017
    1.3 Estrogen and Progesterone, by Antiprogestogen 2012-2017
        1.3.1 Global Estrogen and Progesterone Sales Market Share by Antiprogestogen 2012-2017
        1.3.2 Global Estrogen and Progesterone Revenue Market Share by Antiprogestogen 2012-2017
        1.3.3 Global Estrogen and Progesterone Price by Antiprogestogen 2012-2017
    1.4 Estrogen and Progesterone, by Estrogenic stimulant 2012-2017
        1.4.1 Global Estrogen and Progesterone Sales Market Share by Estrogenic stimulant 2012-2017
        1.4.2 Global Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant 2012-2017
        1.4.3 Global Estrogen and Progesterone Price by Estrogenic stimulant 2012-2017
    1.5 Estrogen and Progesterone, by Antiestrogen agent 2012-2017
        1.5.1 Global Estrogen and Progesterone Sales Market Share by Antiestrogen agent 2012-2017
        1.5.2 Global Estrogen and Progesterone Revenue Market Share by Antiestrogen agent 2012-2017
        1.5.3 Global Estrogen and Progesterone Price by Antiestrogen agent 2012-2017
    1.6 Estrogen and Progesterone, by Aromatase Inhibitor 2012-2017
        1.6.1 Global Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor 2012-2017
        1.6.2 Global Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor 2012-2017
        1.6.3 Global Estrogen and Progesterone Price by Aromatase Inhibitor 2012-2017

Chapter Two United States Estrogen and Progesterone Market Overview
    2.1 United States Estrogen and Progesterone Market Sales Volume Revenue and Price 2012-2017
    2.2 Estrogen and Progesterone, by Progesterone stimulant 2012-2017
        2.2.1 United States Estrogen and Progesterone Sales Market Share by Progesterone stimulant 2012-2017
        2.2.2 United States Estrogen and Progesterone Revenue Market Share by Progesterone stimulant 2012-2017
        2.2.3 United States Estrogen and Progesterone Price by Progesterone stimulant 2012-2017
    2.3 Estrogen and Progesterone, by Antiprogestogen 2012-2017
        2.3.1 United States Estrogen and Progesterone Sales Market Share by Antiprogestogen 2012-2017
        2.3.2 United States Estrogen and Progesterone Revenue Market Share by Antiprogestogen 2012-2017
        2.3.3 United States Estrogen and Progesterone Price by Antiprogestogen 2012-2017
    2.4 Estrogen and Progesterone, by Estrogenic stimulant 2012-2017
        2.4.1 United States Estrogen and Progesterone Sales Market Share by Estrogenic stimulant 2012-2017
        2.4.2 United States Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant 2012-2017
        2.4.3 United States Estrogen and Progesterone Price by Estrogenic stimulant 2012-2017
    2.5 Estrogen and Progesterone, by Antiestrogen agent 2012-2017
        2.5.1 United States Estrogen and Progesterone Sales Market Share by Antiestrogen agent 2012-2017
        2.5.2 United States Estrogen and Progesterone Revenue Market Share by Antiestrogen agent 2012-2017
        2.5.3 United States Estrogen and Progesterone Price by Antiestrogen agent 2012-2017
    2.6 Estrogen and Progesterone, by Aromatase Inhibitor 2012-2017
        2.6.1 United States Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor 2012-2017
        2.6.2 United States Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor 2012-2017
        2.6.3 United States Estrogen and Progesterone Price by Aromatase Inhibitor 2012-2017

Chapter Three Estrogen and Progesterone by Regions 2012-2017
    3.1 Global Estrogen and Progesterone Sales Market Share by Regions 2012-2017
    3.2 Global Estrogen and Progesterone Revenue Market Share by Regions 2012-2017
    3.3 Global Estrogen and Progesterone Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Estrogen and Progesterone by Companies 2012-2017
    4.1 Global Estrogen and Progesterone Sales Volume Market Share by Companies 2012-2017
    4.2 Global Estrogen and Progesterone Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Estrogen and Progesterone Key Product Model and Market Performance
    4.4 Global Top Companies Estrogen and Progesterone Key Target Consumers and Market Performance

Chapter Five United States Estrogen and Progesterone by Companies 2012-2017
    5.1 United States Estrogen and Progesterone Sales Volume Market Share by Companies 2012-2017
    5.2 United States Estrogen and Progesterone Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Estrogen and Progesterone Key Product Model and Market Performance
    5.4 United States Top Companies Estrogen and Progesterone Key Target Consumers and Market Performance

Chapter Six Global Estrogen and Progesterone by Consumer 2012-2017
    6.1 Global Estrogen and Progesterone Sales Market Share by Consumer 2012-2017
    6.2 
    6.3 
    6.2 Consuming Habit and Preference

Chapter Seven Global Estrogen and Progesterone by Consumer 2012-2017
    7.1 Global Estrogen and Progesterone Sales Market Share by Consumer 2012-2017
    7.2 
    7.3 
    7.2 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Gedeon Richter Plc.
        8.1.1 Gedeon Richter Plc. Company Details and Competitors
        8.1.2 Gedeon Richter Plc. Key Estrogen and Progesterone Models and Performance
        8.1.3 Gedeon Richter Plc. Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.1.4 Gedeon Richter Plc. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.2 Bayer Oy
        8.2.1 Bayer Oy Company Details and Competitors
        8.2.2 Bayer Oy Key Estrogen and Progesterone Models and Performance
        8.2.3 Bayer Oy Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.2.4 Bayer Oy Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.3 N.V.Organon
        8.3.1 N.V.Organon Company Details and Competitors
        8.3.2 N.V.Organon Key Estrogen and Progesterone Models and Performance
        8.3.3 N.V.Organon Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.3.4 N.V.Organon Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.4 Pfizer Healthcare Ireland
        8.4.1 Pfizer Healthcare Ireland Company Details and Competitors
        8.4.2 Pfizer Healthcare Ireland Key Estrogen and Progesterone Models and Performance
        8.4.3 Pfizer Healthcare Ireland Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.4.4 Pfizer Healthcare Ireland Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.5 Jenapharm GmbH & Co. KG
        8.5.1 Jenapharm GmbH & Co. KG Company Details and Competitors
        8.5.2 Jenapharm GmbH & Co. KG Key Estrogen and Progesterone Models and Performance
        8.5.3 Jenapharm GmbH & Co. KG Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.5.4 Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.6 Besins Healthcare Benelux
        8.6.1 Besins Healthcare Benelux Company Details and Competitors
        8.6.2 Besins Healthcare Benelux Key Estrogen and Progesterone Models and Performance
        8.6.3 Besins Healthcare Benelux Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.6.4 Besins Healthcare Benelux Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.7 MERCK SERONO LIMITED
        8.7.1 MERCK SERONO LIMITED Company Details and Competitors
        8.7.2 MERCK SERONO LIMITED Key Estrogen and Progesterone Models and Performance
        8.7.3 MERCK SERONO LIMITED Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.7.4 MERCK SERONO LIMITED Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.8 Abbott Healthcare Products B.V.
        8.8.1 Abbott Healthcare Products B.V. Company Details and Competitors
        8.8.2 Abbott Healthcare Products B.V. Key Estrogen and Progesterone Models and Performance
        8.8.3 Abbott Healthcare Products B.V. Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.8.4 Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.9 Teva Pharma - Produtos Farmaceuticos,Lda.
        8.9.1 Teva Pharma - Produtos Farmaceuticos,Lda. Company Details and Competitors
        8.9.2 Teva Pharma - Produtos Farmaceuticos,Lda. Key Estrogen and Progesterone Models and Performance
        8.9.3 Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.9.4 Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.10 Aspen Pharmacare Australia Pty Ltd.
        8.10.1 Aspen Pharmacare Australia Pty Ltd. Company Details and Competitors
        8.10.2 Aspen Pharmacare Australia Pty Ltd. Key Estrogen and Progesterone Models and Performance
        8.10.3 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Business SWOT Analysis and Forecast
        8.10.4 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin
    8.11 Dr.Kade Pharmazeutische Fabrik GmbH
    8.12 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
    8.13 Eli Lilly Nederland B.V
    8.14 Orion Corporation
    8.15 AstraZeneca UK Limited
    8.16 Novartis Pharma Schweiz AG

Chapter Nine Industry Chain and Supply Chain
    9.1 Estrogen and Progesterone Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Estrogen and Progesterone Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Estrogen and Progesterone Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Estrogen and Progesterone Sales (), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)
    10.3 Global Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
    10.4 Global Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)
    10.5 Global Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)
    10.6 Global Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)
    10.7 Global Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)
    10.8 Global Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)

Chapter Eleven United States Estrogen and Progesterone Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Estrogen and Progesterone Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)
    11.3 United States Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
    11.4 United States Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)
    11.5 United States Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)
    11.6 United States Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)
    11.7 United States Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)
    11.8 United States Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Estrogen and Progesterone Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Estrogen and Progesterone Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Estrogen and Progesterone Sales Volume () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales () by Progesterone stimulant (2012-2017)
    Table Global Estrogen and Progesterone Sales Market Share by Progesterone stimulant (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Progesterone stimulant in 2016
    Table Global Estrogen and Progesterone Revenue (Million USD) by Progesterone stimulant (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Progesterone stimulant (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Progesterone stimulant in 2016
    Table Global Estrogen and Progesterone Price () by Progesterone stimulant (2012-2017)
    Table Top Companies of Norethisterone Acetate Estrogen and Progesterone Products List
    Figure Global Norethisterone Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Ethynodiol diacetate Estrogen and Progesterone Products List
    Figure Global Ethynodiol diacetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales () by Antiprogestogen (2012-2017)
    Table Global Estrogen and Progesterone Sales Market Share by Antiprogestogen (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Antiprogestogen in 2016
    Table Global Estrogen and Progesterone Revenue (Million USD) by Antiprogestogen (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Antiprogestogen (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Antiprogestogen in 2016
    Table Global Estrogen and Progesterone Price () by Antiprogestogen (2012-2017)
    Table Top Companies of Aglepristone Estrogen and Progesterone Products List
    Figure Global Aglepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Mifepristone Estrogen and Progesterone Products List
    Figure Global Mifepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales () by Estrogenic stimulant (2012-2017)
    Table Global Estrogen and Progesterone Sales Market Share by Estrogenic stimulant (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Estrogenic stimulant in 2016
    Table Global Estrogen and Progesterone Revenue (Million USD) by Estrogenic stimulant (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant in 2016
    Table Global Estrogen and Progesterone Price () by Estrogenic stimulant (2012-2017)
    Table Top Companies of Megestrol Estrogen and Progesterone Products List
    Figure Global Megestrol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Estradiol Estrogen and Progesterone Products List
    Figure Global Estradiol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Estradiol Acetate Estrogen and Progesterone Products List
    Figure Global Estradiol Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales () by Antiestrogen agent (2012-2017)
    Table Global Estrogen and Progesterone Sales Market Share by Antiestrogen agent (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Antiestrogen agent in 2016
    Table Global Estrogen and Progesterone Revenue (Million USD) by Antiestrogen agent (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Antiestrogen agent (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Antiestrogen agent in 2016
    Table Global Estrogen and Progesterone Price () by Antiestrogen agent (2012-2017)
    Table Top Companies of Afimoxifene Estrogen and Progesterone Products List
    Figure Global Afimoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Arzoxifene Estrogen and Progesterone Products List
    Figure Global Arzoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales () by Aromatase Inhibitor (2012-2017)
    Table Global Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor in 2016
    Table Global Estrogen and Progesterone Revenue (Million USD) by Aromatase Inhibitor (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor in 2016
    Table Global Estrogen and Progesterone Price () by Aromatase Inhibitor (2012-2017)
    Table Top Companies of Aminoglutethimide Estrogen and Progesterone Products List
    Figure Global Aminoglutethimide Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Testolactone Estrogen and Progesterone Products List
    Figure Global Testolactone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Figure United States Estrogen and Progesterone Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Estrogen and Progesterone Sales Volume () and Growth Rate (2012-2017)
    Table United States Estrogen and Progesterone Sales () by Progesterone stimulant (2012-2017)
    Table United States Estrogen and Progesterone Sales Market Share by Progesterone stimulant (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Progesterone stimulant in 2016
    Table United States Estrogen and Progesterone Revenue (Million USD) by Progesterone stimulant (2012-2017)
    Table United States Estrogen and Progesterone Revenue Market Share by Progesterone stimulant (2012-2017)
    Figure United States Estrogen and Progesterone Revenue Market Share by Progesterone stimulant in 2016
    Table United States Estrogen and Progesterone Price () by Progesterone stimulant (2012-2017)
    Table Top Companies of Norethisterone Acetate Estrogen and Progesterone Products List
    Figure United States Norethisterone Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Ethynodiol diacetate Estrogen and Progesterone Products List
    Figure United States Ethynodiol diacetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table United States Estrogen and Progesterone Sales () by Antiprogestogen (2012-2017)
    Table United States Estrogen and Progesterone Sales Market Share by Antiprogestogen (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Antiprogestogen in 2016
    Table United States Estrogen and Progesterone Revenue (Million USD) by Antiprogestogen (2012-2017)
    Table United States Estrogen and Progesterone Revenue Market Share by Antiprogestogen (2012-2017)
    Figure United States Estrogen and Progesterone Revenue Market Share by Antiprogestogen in 2016
    Table United States Estrogen and Progesterone Price () by Antiprogestogen (2012-2017)
    Table Top Companies of Aglepristone Estrogen and Progesterone Products List
    Figure United States Aglepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Mifepristone Estrogen and Progesterone Products List
    Figure United States Mifepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table United States Estrogen and Progesterone Sales () by Estrogenic stimulant (2012-2017)
    Table United States Estrogen and Progesterone Sales Market Share by Estrogenic stimulant (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Estrogenic stimulant in 2016
    Table United States Estrogen and Progesterone Revenue (Million USD) by Estrogenic stimulant (2012-2017)
    Table United States Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant (2012-2017)
    Figure United States Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant in 2016
    Table United States Estrogen and Progesterone Price () by Estrogenic stimulant (2012-2017)
    Table Top Companies of Megestrol Estrogen and Progesterone Products List
    Figure United States Megestrol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Estradiol Estrogen and Progesterone Products List
    Figure United States Estradiol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Estradiol Acetate Estrogen and Progesterone Products List
    Figure United States Estradiol Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table United States Estrogen and Progesterone Sales () by Antiestrogen agent (2012-2017)
    Table United States Estrogen and Progesterone Sales Market Share by Antiestrogen agent (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Antiestrogen agent in 2016
    Table United States Estrogen and Progesterone Revenue (Million USD) by Antiestrogen agent (2012-2017)
    Table United States Estrogen and Progesterone Revenue Market Share by Antiestrogen agent (2012-2017)
    Figure United States Estrogen and Progesterone Revenue Market Share by Antiestrogen agent in 2016
    Table United States Estrogen and Progesterone Price () by Antiestrogen agent (2012-2017)
    Table Top Companies of Afimoxifene Estrogen and Progesterone Products List
    Figure United States Afimoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Arzoxifene Estrogen and Progesterone Products List
    Figure United States Arzoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table United States Estrogen and Progesterone Sales () by Aromatase Inhibitor (2012-2017)
    Table United States Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor in 2016
    Table United States Estrogen and Progesterone Revenue (Million USD) by Aromatase Inhibitor (2012-2017)
    Table United States Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor (2012-2017)
    Figure United States Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor in 2016
    Table United States Estrogen and Progesterone Price () by Aromatase Inhibitor (2012-2017)
    Table Top Companies of Aminoglutethimide Estrogen and Progesterone Products List
    Figure United States Aminoglutethimide Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Top Companies of Testolactone Estrogen and Progesterone Products List
    Figure United States Testolactone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table Global Estrogen and Progesterone Sales Share by Regions (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Regions in 2016
    Figure Global Estrogen and Progesterone Sales Market Share by Regions in 2017
    Table Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Regions (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Regions in 2016
    Figure Global Estrogen and Progesterone Revenue Market Share by Regions in 2017
    Table Global Estrogen and Progesterone Price () by Regions (2012-2017)
    Table North America Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table North America Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)
    Figure North America Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table United States Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table United States Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)
    Figure United States Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Latin America Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table Latin America Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Europe Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table Europe Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table Asia & Pacific Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Estrogen and Progesterone Sales () by Regions (2012-2017)
    Table Africa & Middle East Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Estrogen and Progesterone Sales () and Growth Rate (2012-2017)
    Table Global Estrogen and Progesterone Sales Volume () by Major Companies (2012-2017)
    Table Global Estrogen and Progesterone Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Estrogen and Progesterone Sales Volume Market Share by Major Companies 2016
    Figure Global Estrogen and Progesterone Sales Volume Market Share by Major Companies 2017
    Table Global Estrogen and Progesterone Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Estrogen and Progesterone Revenue Market Share by Major Companies (2012-2017)
    Figure Global Estrogen and Progesterone Revenue Market Share by Major Companies 2016
    Figure Global Estrogen and Progesterone Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Estrogen and Progesterone Sales Volume () by Top Companies (2012-2017)
    Table United States Estrogen and Progesterone Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Estrogen and Progesterone Sales Volume Market Share by Top Companies 2016
    Figure United States Estrogen and Progesterone Sales Volume Market Share by Top Companies 2017
    Table United States Estrogen and Progesterone Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Estrogen and Progesterone Revenue Market Share by Top Companies (2012-2017)
    Figure United States Estrogen and Progesterone Revenue Market Share by Top Companies 2016
    Figure United States Estrogen and Progesterone Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Estrogen and Progesterone Sales () by Consumer (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Consumer (2012-2017)
    Figure Global Estrogen and Progesterone Sales Market Share by Consumer in 2016
    Table United States Estrogen and Progesterone Sales () by Consumer (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Consumer (2012-2017)
    Figure United States Estrogen and Progesterone Sales Market Share by Consumer in 2016
    Table Gedeon Richter Plc. Company Details and Competitors
    Table Gedeon Richter Plc. Key Estrogen and Progesterone Models and Performance
    Table Gedeon Richter Plc. Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Gedeon Richter Plc. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Gedeon Richter Plc. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Gedeon Richter Plc. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Gedeon Richter Plc. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Gedeon Richter Plc. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Bayer Oy Company Details and Competitors
    Table Bayer Oy Key Estrogen and Progesterone Models and Performance
    Table Bayer Oy Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Bayer Oy Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Bayer Oy Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer Oy Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Bayer Oy Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer Oy Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table N.V.Organon Company Details and Competitors
    Table N.V.Organon Key Estrogen and Progesterone Models and Performance
    Table N.V.Organon Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table N.V.Organon Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure N.V.Organon Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure N.V.Organon Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure N.V.Organon Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure N.V.Organon Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer Healthcare Ireland Company Details and Competitors
    Table Pfizer Healthcare Ireland Key Estrogen and Progesterone Models and Performance
    Table Pfizer Healthcare Ireland Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Pfizer Healthcare Ireland Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Pfizer Healthcare Ireland Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer Healthcare Ireland Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer Healthcare Ireland Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer Healthcare Ireland Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Jenapharm GmbH & Co. KG Company Details and Competitors
    Table Jenapharm GmbH & Co. KG Key Estrogen and Progesterone Models and Performance
    Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Besins Healthcare Benelux Company Details and Competitors
    Table Besins Healthcare Benelux Key Estrogen and Progesterone Models and Performance
    Table Besins Healthcare Benelux Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Besins Healthcare Benelux Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Besins Healthcare Benelux Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Besins Healthcare Benelux Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Besins Healthcare Benelux Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Besins Healthcare Benelux Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table MERCK SERONO LIMITED Company Details and Competitors
    Table MERCK SERONO LIMITED Key Estrogen and Progesterone Models and Performance
    Table MERCK SERONO LIMITED Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table MERCK SERONO LIMITED Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure MERCK SERONO LIMITED Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure MERCK SERONO LIMITED Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure MERCK SERONO LIMITED Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure MERCK SERONO LIMITED Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Abbott Healthcare Products B.V. Company Details and Competitors
    Table Abbott Healthcare Products B.V. Key Estrogen and Progesterone Models and Performance
    Table Abbott Healthcare Products B.V. Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Abbott Healthcare Products B.V. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Teva Pharma - Produtos Farmaceuticos,Lda. Company Details and Competitors
    Table Teva Pharma - Produtos Farmaceuticos,Lda. Key Estrogen and Progesterone Models and Performance
    Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Aspen Pharmacare Australia Pty Ltd. Company Details and Competitors
    Table Aspen Pharmacare Australia Pty Ltd. Key Estrogen and Progesterone Models and Performance
    Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Business SWOT Analysis and Forecast
    Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)
    Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)
    Table Dr.Kade Pharmazeutische Fabrik GmbH Company Details and Competitors
    Table F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Company Details and Competitors
    Table Eli Lilly Nederland B.V Company Details and Competitors
    Table Orion Corporation Company Details and Competitors
    Table AstraZeneca UK Limited Company Details and Competitors
    Table Novartis Pharma Schweiz AG Company Details and Competitors
    Figure Global Estrogen and Progesterone Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Estrogen and Progesterone Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Estrogen and Progesterone Price () Trend Forecast (2017-2022)
    Table Global Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)
    Table Global Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Share Forecast by Regions in 2022
    Table Global Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Application in 2022
    Table Global Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)
    Figure Global Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Progesterone stimulant in 2022
    Table Global Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)
    Figure Global Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Antiprogestogen in 2022
    Table Global Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)
    Figure Global Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Estrogenic stimulant in 2022
    Table Global Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)
    Figure Global Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Antiestrogen agent in 2022
    Table Global Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)
    Figure Global Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)
    Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Aromatase Inhibitor in 2022
    Figure United States Estrogen and Progesterone Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure United States Estrogen and Progesterone Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Estrogen and Progesterone Price () Trend Forecast (2017-2022)
    Table United States Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)
    Table United States Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Share Forecast by Regions in 2022
    Table United States Estrogen and Progesterone Sales () Forecast by Application (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Application in 2022
    Table United States Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)
    Figure United States Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Progesterone stimulant in 2022
    Table United States Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)
    Figure United States Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Antiprogestogen in 2022
    Table United States Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)
    Figure United States Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Estrogenic stimulant in 2022
    Table United States Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)
    Figure United States Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Antiestrogen agent in 2022
    Table United States Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)
    Figure United States Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)
    Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Aromatase Inhibitor in 2022